coenzyme Q10/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Increases flow-mediated dilation
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.Findingreplicated ×1“CoQ10 increased brachial artery FMD by mean ± SEM 1.0 ± 0.5% (P = 0.04) compared with placebo but did not alter nitrate-mediated dilatation (P = 0.66).”
Quoted verbatim from Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients.. - Study
- crossover
- Duration
- 3 months
- Dose
- 200 mg/day
- Population
- Statin-treated type 2 diabetic patients aged 40-79 years with endothelial dysfunction (brachial FMD <5.5%) and LDL cholesterol <2.5 mmol/l; double-blind crossover versus placebo
Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients.2009PMID:19228872Permalink
Keep reading
- Everything the graph holds on coenzyme Q10
- Every compound studied against Flow-mediated dilation
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PD2M75225W1DN28HHEFH0N